Cash from Financing (Quarterly) Chart

View Cash from Financing (Quarterly) for SNDA.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Cash from Financing (Quarterly) Chart
Start Trial

Historical Cash from Financing (Quarterly) Data

View and export this data back to 1998. Start Trial.
Date Value
June 30, 2026 -41.03M
March 31, 2026 1.029B
December 31, 2025 3.334M
September 30, 2025 14.72M
June 30, 2025 21.59M
March 31, 2025 -2.416M
December 31, 2024 53.10M
September 30, 2024 120.77M
June 30, 2024 21.22M
March 31, 2024 29.15M
December 31, 2023 0.328M
September 30, 2023 -1.137M
June 30, 2023 -2.545M
March 31, 2023 -3.759M
December 31, 2022 1.652M
September 30, 2022 -4.358M
June 30, 2022 -6.512M
March 31, 2022 -13.43M
December 31, 2021 92.83M
September 30, 2021 12.12M
June 30, 2021 -3.265M
March 31, 2021 -2.275M
December 31, 2020 -7.314M
September 30, 2020 -2.811M
June 30, 2020 -0.557M
Date Value
March 31, 2020 -5.235M
December 31, 2019 -46.86M
September 30, 2019 -6.013M
June 30, 2019 -2.791M
March 31, 2019 -4.605M
December 31, 2018 15.58M
September 30, 2018 -6.238M
June 30, 2018 -4.479M
March 31, 2018 -6.528M
December 31, 2017 4.944M
September 30, 2017 -6.104M
June 30, 2017 -3.951M
March 31, 2017 58.16M
December 31, 2016 32.51M
September 30, 2016 36.74M
June 30, 2016 19.09M
March 31, 2016 38.50M
December 31, 2015 62.66M
September 30, 2015 33.35M
June 30, 2015 17.60M
March 31, 2015 16.72M
December 31, 2014 19.27M
September 30, 2014 32.92M
June 30, 2014 96.21M
March 31, 2014 6.301M

Cash From Financing Definition

Represents the net cash flow resulting from the company's financing activities. Financing activities represent movement in the company's debt and share capital and other activities.

Read full definition.

Cash from Financing (Quarterly) Range, Past 5 Years

View Cash from Financing (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Cash from Financing (Quarterly) Benchmarks

View Cash from Financing (Quarterly) Benchmarks
Start Trial
Astrana Health, Inc. -104.07M
The Joint Corp. (United States) -0.6953M
Starling Oncology, Inc. -0.218M
Nutex Health, Inc. -35.19M
Concentra Group Holdings Parent, Inc. -24.67M